BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 6, 2013
View Archived Issues
Janssen presents phase III results from QUEST-2 and PROMISE trials of simeprevir
Read More
UMC Utrecht Holding divulges new fusion proteins
Read More
Shionogi and TB alliance set to collaborate
Read More
Allergan advances novel glaucoma compound into preclinical development
Read More
Researchers at Variation Biotechnologies patent new vaccines for HCMV infection
Read More
First-in-human evaluation of a DNAzyme in adults with nodular basal cell carcinoma
Read More
CSL Behring doses first patient in part 3 of global AFFINITY trial program
Read More
Researchers from MD Anderson Cancer Center present novel cancer gene therapy
Read More
PhaseBio begins first-in-human phase I study of long-acting basal insulin for diabetes
Read More
NIH will fund antibacterial resistance research network at Duke University
Read More
The Medicines Company enters agreement to acquire ProFibrix
Read More
NB Health Laboratory and Mercachem expand partnership
Read More
Prolor Biotech begins pivotal phase III trial of hGH-CTP
Read More
First-in-human data for vantictumab, an antibody targeting the Wnt pathway
Read More
Tunitas Therapeutics receives phase II SBIR grant to advance asthma program
Read More
Phase II Pluristem Therapeutics trial to be put on clinical hold
Read More
IL-23 receptor modulator peptide shows potential in animal models of arthritis
Read More
BTF as a biomarker of severe events in patients with AF
Read More
Bayer acquires majority interest in Conceptus
Read More
FDA grants fast track designation to NNZ-2566 in Rett syndrome
Read More
Almirall patents novel agents for respiratory disorders
Read More
The Vanderbilt University discloses new allosteric modulators of the M1 receptor
Read More
Novel XIAP inhibitors presented by Bristol-Myers Squibb and Ensemble Therapeutics
Read More
Researchers at Allergan design novel FPRL1 ligands
Read More
BioMarin commences phase III program for PKU treatment candidate
Read More
FDA approves lenalidomide for relapsed/refractory mantle cell lymphoma
Read More